• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国儿童感染 2019 年冠状病毒病疫苗接种的短期影响。

Short Term Impact of Coronavirus Disease 2019 Vaccination in Children in Korea.

机构信息

Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea.

Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.

出版信息

J Korean Med Sci. 2022 May 2;37(17):e124. doi: 10.3346/jkms.2022.37.e124.

DOI:10.3346/jkms.2022.37.e124
PMID:35502499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9062273/
Abstract

BACKGROUND

The epidemiology of coronavirus disease 2019 (COVID-19) has changed continuously throughout the pandemic.

METHODS

We analyzed changes in the incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection according to the age group in South Korea from February 2020 to December 2021.

RESULTS

Since the COVID-19 pandemic, the incidence among adults aged ≥ 18 years was higher than all the other age groups in 2020; however, a shift toward younger ages occurred in June 2021. In addition, we found significant changes in epidemiology after the introduction of SARS-CoV-2 vaccines in adults aged ≥ 18 and children 12-17 years. Until recently, children were not regarded as the drive for the pandemic; however, children aged 5-11 and 0-4 years had the highest incidence among all the age groups.

CONCLUSION

Therefore, policies for clinical support for an increase in COVID-19 cases among young children and age-specific preventive measures are needed.

摘要

背景

2019 年冠状病毒病(COVID-19)的流行病学在整个大流行期间不断变化。

方法

我们根据韩国 2020 年 2 月至 2021 年 12 月的年龄组分析了严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染发病率的变化。

结果

自 COVID-19 大流行以来,2020 年≥18 岁成年人的发病率高于所有其他年龄组;然而,2021 年 6 月这种情况向年轻人群转移。此外,我们发现 SARS-CoV-2 疫苗在≥18 岁成年人和 12-17 岁儿童中接种后,流行病学发生了显著变化。直到最近,儿童还不被认为是大流行的驱动因素;然而,5-11 岁和 0-4 岁的儿童在所有年龄组中发病率最高。

结论

因此,需要制定针对年轻儿童 COVID-19 病例增加的临床支持政策和特定年龄组的预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51cb/9062273/f600ee6d06f1/jkms-37-e124-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51cb/9062273/f600ee6d06f1/jkms-37-e124-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51cb/9062273/f600ee6d06f1/jkms-37-e124-g001.jpg

相似文献

1
Short Term Impact of Coronavirus Disease 2019 Vaccination in Children in Korea.韩国儿童感染 2019 年冠状病毒病疫苗接种的短期影响。
J Korean Med Sci. 2022 May 2;37(17):e124. doi: 10.3346/jkms.2022.37.e124.
2
Can we get out of the COVID pandemic without adequate vaccination coverage in the pediatric population?在儿科人群中没有足够的疫苗接种覆盖率的情况下,我们能摆脱 COVID 大流行吗?
Ital J Pediatr. 2022 Aug 19;48(1):150. doi: 10.1186/s13052-022-01339-x.
3
Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.制定大流行 COVID-19 疫苗分配框架:韩国的一项改良德尔菲共识研究。
J Korean Med Sci. 2021 Jun 14;36(23):e166. doi: 10.3346/jkms.2021.36.e166.
4
Projecting the Impact of SARS-CoV-2 Variants and the Vaccination Program on the Fourth Wave of the COVID-19 Pandemic in South Korea.预测新冠病毒变异株和疫苗接种计划对韩国第四波新冠疫情的影响
Int J Environ Res Public Health. 2021 Jul 16;18(14):7578. doi: 10.3390/ijerph18147578.
5
The Seroprevalence of SARS-CoV-2 in Children During Early COVID-19 Pandemic in Korea: A Nationwide, Population-Based Study.韩国 COVID-19 大流行早期儿童中 SARS-CoV-2 的血清流行率:一项全国性、基于人群的研究。
J Korean Med Sci. 2022 Nov 14;37(44):e314. doi: 10.3346/jkms.2022.37.e314.
6
Disparities in First Dose COVID-19 Vaccination Coverage among Children 5-11 Years of Age, United States.儿童 5-11 岁人群中 COVID-19 疫苗首剂接种覆盖率的差异,美国。
Emerg Infect Dis. 2022 May;28(5):986-989. doi: 10.3201/eid2805.220166. Epub 2022 Feb 28.
7
Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.COVID-19 大流行期间儿童及其父母呼吸道疾病的纵向家庭评估。
JAMA Netw Open. 2022 Oct 3;5(10):e2237522. doi: 10.1001/jamanetworkopen.2022.37522.
8
Pediatricians' perceptions, practices, and barriers regarding COVID-19 vaccine for children: A cross-sectional survey in Ontario, Canada.儿科医生对儿童 COVID-19 疫苗的看法、实践和障碍:加拿大安大略省的一项横断面调查。
Vaccine. 2023 May 5;41(19):3058-3065. doi: 10.1016/j.vaccine.2023.03.041. Epub 2023 Apr 3.
9
Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.韩国2019冠状病毒病儿科患者的特征。
J Korean Med Sci. 2021 May 24;36(20):e148. doi: 10.3346/jkms.2021.36.e148.
10
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.

引用本文的文献

1
Excess mortality during the Coronavirus disease pandemic in Korea.韩国冠状病毒病大流行期间的超额死亡率。
BMC Public Health. 2023 Sep 2;23(1):1698. doi: 10.1186/s12889-023-16546-2.
2
Change in Severity and Clinical Manifestation of MIS-C Over SARS-CoV-2 Variant Outbreaks in Korea.韩国在 SARS-CoV-2 变异株流行期间,川崎病样疾病严重程度和临床表现的变化。
J Korean Med Sci. 2023 Jul 31;38(30):e225. doi: 10.3346/jkms.2023.38.e225.
3
Phylodynamic analysis revealed that human mobility and vaccination were correlated to the local spread of SARS-CoV-2 in Republic of Korea.

本文引用的文献

1
Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents.BNT162b2 mRNA 新冠疫苗在青少年中的安全性和有效性。
Vaccine. 2022 Jan 31;40(5):691-694. doi: 10.1016/j.vaccine.2021.12.044. Epub 2021 Dec 24.
2
Analysis of Critical COVID-19 Cases Among Children in Korea.韩国儿童危重症 COVID-19 病例分析。
J Korean Med Sci. 2022 Jan 3;37(1):e13. doi: 10.3346/jkms.2022.37.e13.
3
SARS-CoV-2 transmission in schools in Korea: nationwide cohort study.韩国学校中 SARS-CoV-2 的传播:全国队列研究。
系统发育动力学分析显示,在韩国,人类的流动性和疫苗接种与 SARS-CoV-2 的本地传播相关。
Emerg Microbes Infect. 2023 Dec;12(2):2228934. doi: 10.1080/22221751.2023.2228934.
4
Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study.一般人群中 SARS-CoV-2 的再感染,韩国;全国回顾性队列研究。
J Med Virol. 2022 Nov;94(11):5589-5592. doi: 10.1002/jmv.28026. Epub 2022 Aug 2.
Arch Dis Child. 2022 Mar;107(3):e20. doi: 10.1136/archdischild-2021-322355. Epub 2021 Dec 2.
4
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021.免疫实践咨询委员会关于在 5-11 岁儿童中使用辉瑞-生物技术公司 COVID-19 疫苗的临时建议-美国,2021 年 11 月。
MMWR Morb Mortal Wkly Rep. 2021 Nov 12;70(45):1579-1583. doi: 10.15585/mmwr.mm7045e1.
5
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.Delta 变异株导致的指数级增长、高 SARS-CoV-2 流行率和疫苗效力。
Science. 2021 Dec 17;374(6574):eabl9551. doi: 10.1126/science.abl9551.
6
Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0-17 Years - United States, August 2020-August 2021.2020 年 8 月至 2021 年 8 月期间,0-17 岁儿童和青少年的 COVID-19 病例、急诊就诊和住院趋势-美国。
MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1249-1254. doi: 10.15585/mmwr.mm7036e1.
7
Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School - Marin County, California, May-June 2021.与 SARS-CoV-2 B.1.617.2(德尔塔)变异株相关的疫情在加利福尼亚州马里恩县的一所小学爆发 - 2021 年 5 月至 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Sep 3;70(35):1214-1219. doi: 10.15585/mmwr.mm7035e2.
8
Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021.COVID-19 疫苗在预防≥65 岁成年人住院方面的有效性 - COVID-NET,13 个州,2021 年 2 月至 4 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1088-1093. doi: 10.15585/mmwr.mm7032e3.
9
Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.制定大流行 COVID-19 疫苗分配框架:韩国的一项改良德尔菲共识研究。
J Korean Med Sci. 2021 Jun 14;36(23):e166. doi: 10.3346/jkms.2021.36.e166.
10
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.辉瑞-生物科技疫苗和牛津-阿斯利康疫苗对英格兰老年人新冠病毒相关症状、住院及死亡率的有效性:检测阴性病例对照研究
BMJ. 2021 May 13;373:n1088. doi: 10.1136/bmj.n1088.